Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | HCID 68872990 | HCID 68872990 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Potassium Carbonate | HCID 11430 | — |
| Product | Trifluoroacetate | HCID 84468 | — |
| Product | HCID 11856773 | HCID 11856773 | — |
Reaction Steps
5-{(4S,5R)-4,5-Bis-(4-chloro-phenyl)-1-[4-(2-morpholin-4-yl-2-oxo-ethyl)-piperazine-1-carbonyl]-4,5-dihydro-1H-imidazol-2-yl}-N-tert-butyl-2-chloro-4-ethoxy-benzenesulfonamide (˜10 mg) was dissolved in 2 mL of trifluoroacetic acid and heated to 80° C. for 30 min. The reaction mixture was diluted with 2 mL of methylene chloride and 1.5 mL of 10% potassium carbonate solution then agitated. The organic layer was separated and concentrated in vacuo to give 5-{(4S,5R)-4,5-bis-(4-chloro-phenyl)-1-[4-(2-morpholin-4-yl-2-oxo-ethyl)-piperazine-1-carbonyl]-4,5-dihydro-1H-imidazol-2-yl}-2-chloro-4-ethoxy-benzenesulfonamide as trifluoroacetate salt. LC-MS: 763.3 [(M+H)+].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07579368B2 |
|---|
| Source dataset | uspto-grants-2009_08 |
|---|
| ORD ID | ord-edf272debd6c4d36a6b17ce336cba1e7 |
|---|
| Source note | uspto-grants-2009_08 |
|---|